{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:36Z","timestamp":1791404616877,"version":"4.3.3"},"reference-count":210,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health (MS, FT)","doi-asserted-by":"publisher","award":["PERMEALS PNRR-MAD-2022-12375731"],"award-info":[{"award-number":["PERMEALS PNRR-MAD-2022-12375731"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Motor Neuron Diseases (MNDs) such as Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS), Hereditary Spastic Paraplegia (HSP), Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1), Multisystem Proteinopathy (MSP), Spinal and Bulbar Muscular Atrophy (SBMA), and ALS associated to Frontotemporal Dementia (ALS-FTD), have traditionally been studied as distinct entities, each one with unique genetic and clinical characteristics. However, emerging research reveals that these seemingly disparate conditions converge on shared molecular mechanisms that drive progressive neuroaxonal degeneration. This narrative review addresses a critical gap in the field by synthesizing the most recent findings into a comprehensive, cross-disease mechanisms framework. By integrating insights into RNA dysregulation, protein misfolding, mitochondrial dysfunction, DNA damage, kinase signaling, axonal transport failure, and immune activation, we highlight how these converging pathways create a common pathogenic landscape across MNDs. Importantly, this perspective not only reframes MNDs as interconnected neurodegenerative models but also identifies shared therapeutic targets and emerging strategies, including antisense oligonucleotides, autophagy modulators, kinase inhibitors, and immunotherapies that transcend individual disease boundaries. The diagnostic and prognostic potential of Neurofilament Light Chain (NfL) biomarkers is also emphasized. By shifting focus from gene-specific to mechanism-based approaches, this paper offers a much-needed roadmap for advancing both research and clinical management in MNDs, paving the way for cross-disease therapeutic innovations.<\/jats:p>","DOI":"10.3390\/ijms26157644","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T12:15:40Z","timestamp":1754568940000},"page":"7644","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9887-5304","authenticated-orcid":false,"given":"Minoo","family":"Sharbafshaaer","sequence":"first","affiliation":[{"name":"First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pepe","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, MRI Research Center, University of Campania \u201cLuigi Vanvitelli\u201d, 81038 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6048-9480","authenticated-orcid":false,"given":"Rosaria","family":"Notariale","sequence":"additional","affiliation":[{"name":"First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Canale","sequence":"additional","affiliation":[{"name":"First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Advanced Medical and Surgical Sciences, MRI Research Center, University of Campania \u201cLuigi Vanvitelli\u201d, 81038 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[{"name":"First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Advanced Medical and Surgical Sciences, MRI Research Center, University of Campania \u201cLuigi Vanvitelli\u201d, 81038 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioacchino","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Advanced Medical and Surgical Sciences, MRI Research Center, University of Campania \u201cLuigi Vanvitelli\u201d, 81038 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3790-8018","authenticated-orcid":false,"given":"Francesca","family":"Trojsi","sequence":"additional","affiliation":[{"name":"First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Advanced Medical and Surgical Sciences, MRI Research Center, University of Campania \u201cLuigi Vanvitelli\u201d, 81038 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: A critical review","volume":"10","author":"Logroscino","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00415-018-8881-0","article-title":"Motor neuron disease of paraneoplastic origin: A rare but treatable condition","volume":"265","author":"Berzero","year":"2018","journal-title":"J. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","article-title":"Selective neuronal vulnerability in neurodegenerative diseases: From stressor thresholds to degeneration","volume":"71","author":"Saxena","year":"2011","journal-title":"Neuron"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: From genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.011","article-title":"RNA metabolism in neurological disease","volume":"1584","author":"Gao","year":"2014","journal-title":"Brain Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1523\/JNEUROSCI.0388-10.2010","article-title":"Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy","volume":"30","author":"Katsuno","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/ijms13011225","article-title":"Disruption of axonal transport in motor neuron diseases","volume":"13","author":"Ikenaka","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhao, J., Wang, X., Huo, Z., Chen, Y., Liu, J., Zhao, Z., Meng, F., Su, Q., Bao, W., and Zhang, L. (2022). The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Cells, 11.","DOI":"10.3390\/cells11132049"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","article-title":"Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies","volume":"18","author":"Beers","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Xu, Z., Henderson, R.D., David, M., and McCombe, P.A. (2016). Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164625"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., and Patel, B.K. (2019). Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00025"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Xue, Y.C., Ng, C.S., Xiang, P., Liu, H., Zhang, K., Mohamud, Y., and Luo, H. (2020). Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 13.","DOI":"10.3389\/fnmol.2020.00078"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26508\/lsa.202302554","article-title":"IGHMBP2 deletion suppresses translation and activates the integrated stress response","volume":"7","author":"Park","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1038\/s41467-023-41033-y","article-title":"Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/brain\/awu120","article-title":"Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions","volume":"137","author":"Walsh","year":"2014","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-020-02252-5","article-title":"Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis","volume":"141","author":"Mehta","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Butti, Z., and Patten, S.A. (2018). RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00712"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/nan.12147","article-title":"Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions","volume":"41","author":"Raman","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1007\/s00415-023-11746-7","article-title":"Genetic characterization of primary lateral sclerosis","volume":"270","author":"Pennings","year":"2023","journal-title":"J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s44318-024-00352-6","article-title":"RNA dysregulation in neurodegenerative diseases","volume":"44","author":"Li","year":"2025","journal-title":"EMBO J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/brain\/aww111","article-title":"Genetic and phenotypic characterization of complex hereditary spastic paraplegia","volume":"139","author":"Kara","year":"2016","journal-title":"Brain"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Toupenet Marchesi, L., Stockholm, D., Esteves, T., Leblanc, M., Auger, N., Branchu, J., El Hachimi, K.H., and Stevanin, G. (2025). Transcriptomic analysis reinforces the implication of spatacsin in neuroinflammation and neurodevelopment. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-86337-9"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00401-023-02675-w","article-title":"Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients","volume":"147","author":"Krumm","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wali, G., Li, Y., Liyanage, E., Kumar, K.R., Day, M.L., and Sue, C.M. (2023). Pharmacological rescue of mitochondrial and neuronal defects in SPG7 hereditary spastic paraplegia patient neurons using high throughput assays. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1231584"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng703","article-title":"Mutations in the gene encoding immunoglobulin \u03bc-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1","volume":"29","author":"Grohmann","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tian, Y., Xing, J., Shi, Y., and Yuan, E. (2023). Exploring the relationship between IGHMBP2 gene mutations and spinal muscular atrophy with respiratory distress type 1 and Charcot-Marie-Tooth disease type 2S: A systematic review. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1252075"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jablonka, S., and Yildirim, E. (2024). Disease Mechanisms and Therapeutic Approaches in SMARD1-Insights from Animal Models and Cell Models. Biomedicines, 12.","DOI":"10.3390\/biomedicines12040845"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/hmg\/ddp028","article-title":"IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)","volume":"18","author":"Guenther","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e148363","DOI":"10.1172\/jci.insight.148363","article-title":"Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation","volume":"6","author":"Beijer","year":"2021","journal-title":"JCI Insight"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature11922","article-title":"Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS","volume":"495","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pfeffer, G., Lee, G., Pontifex, C.S., Fanganiello, R.D., Peck, A., Weihl, C.C., and Kimonis, V. (2022). Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis. Genes, 13.","DOI":"10.3390\/genes13060963"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Johnson, M.A., Klickstein, J.A., Khanna, R., Gou, Y., and Raman, M. (2022). The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1). Neurobiol. Dis., 169.","DOI":"10.1016\/j.nbd.2022.105722"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"Wilson","year":"1991","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.410440216","article-title":"Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy","volume":"44","author":"Li","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2017.07.005","article-title":"From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?","volume":"465","author":"Pennuto","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hirunagi, T., Sahashi, K., Meilleur, K.G., and Katsuno, M. (2022). Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders. Genes, 13.","DOI":"10.3390\/genes13010109"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2013.07.038","article-title":"Altered ribostasis: RNA-protein granules in degenerative disorders","volume":"154","author":"Ramaswami","year":"2013","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41467-025-59679-1","article-title":"Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS","volume":"16","author":"Schweingruber","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1752-8062.2012.00407.x","article-title":"Global gene profiling of VCP-associated inclusion body myopathy","volume":"5","author":"Nalbandian","year":"2012","journal-title":"Clin. Transl. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-023-00639-y","article-title":"Valosin containing protein (VCP): Initiator, modifier, and potential drug target for neurodegenerative diseases","volume":"18","author":"Chu","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajhg.2013.04.011","article-title":"Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy","volume":"92","author":"Neveling","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.expneurol.2018.06.008","article-title":"The human motor neuron axonal transcriptome is enriched for transcripts related to mitochondrial function and microtubule-based axonal transport","volume":"307","author":"Maciel","year":"2018","journal-title":"Exp. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41583-019-0222-5","article-title":"Stress granules and neurodegeneration","volume":"20","author":"Wolozin","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-025-00851-y","article-title":"RNA-binding proteins in ALS and FTD: From pathogenic mechanisms to therapeutic insights","volume":"20","author":"Rummens","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2013.02.029","article-title":"VCP is essential for mitochondrial quality control by PINK1\/Parkin and this function is impaired by VCP mutations","volume":"78","author":"Kim","year":"2013","journal-title":"Neuron"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"fcae239","DOI":"10.1093\/braincomms\/fcae239","article-title":"Role of senataxin in R-loop-mediated neurodegeneration","volume":"6","author":"Kannan","year":"2024","journal-title":"Brain Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00401-019-01998-x","article-title":"FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy","volume":"138","author":"Marrone","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41582-019-0257-2","article-title":"Axonal transport and neurological disease","volume":"15","author":"Sleigh","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e82228","DOI":"10.7554\/eLife.82228","article-title":"Kinesin-1, -2, and -3 motors use family-specific mechanochemical strategies to effectively compete with dynein during bidirectional transport","volume":"11","author":"Gicking","year":"2022","journal-title":"Elife"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41580-022-00491-w","article-title":"Selective motor activation in organelle transport along axons","volume":"23","author":"Cason","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tibs.2015.08.003","article-title":"Regulation of Axonal Transport by Protein Kinases","volume":"40","author":"Gibbs","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"McAlary, L., Plotkin, S.S., Yerbury, J.J., and Cashman, N.R. (2019). Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00262"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1042\/BCJ20160499","article-title":"RNA-binding proteins with prion-like domains in health and disease","volume":"474","author":"Harrison","year":"2017","journal-title":"Biochem. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1073\/pnas.1017275108","article-title":"Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells","volume":"108","author":"Bertolotti","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41589-024-01672-8","article-title":"Direct observation of prion-like propagation of protein misfolding templated by pathogenic mutants","volume":"20","author":"Neupane","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"40286","DOI":"10.1021\/acsomega.4c04119","article-title":"Conformational Enigma of TDP-43 Misfolding in Neurodegenerative Disorders","volume":"9","author":"Pillai","year":"2024","journal-title":"ACS Omega"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/bs.pmbts.2024.03.008","article-title":"Chapter Eleven\u2014Therapeutic approaches in proteinopathies","volume":"Volume 206","author":"Dabirmanesh","year":"2024","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2019.01.048","article-title":"RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43","volume":"102","author":"Mann","year":"2019","journal-title":"Neuron"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12031-011-9610-7","article-title":"Rodent models of TDP-43 proteinopathy: Investigating the mechanisms of TDP-43-mediated neurodegeneration","volume":"45","author":"Gendron","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Cantara, S., Simoncelli, G., and Ricci, C. (2024). Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202402.1738.v1"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/21678421.2020.1790607","article-title":"TDP-43 pathology in primary lateral sclerosis","volume":"21","author":"Mackenzie","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molcel.2018.02.025","article-title":"Systematic Characterization of Stress-Induced RNA Granulation","volume":"70","author":"Namkoong","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.neuron.2021.06.023","article-title":"RNA modulates physiological and neuropathological protein phase transitions","volume":"109","author":"Mann","year":"2021","journal-title":"Neuron"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41419-021-03873-8","article-title":"Stress granules, RNA-binding proteins and polyglutamine diseases: Too much aggregation?","volume":"12","author":"Marcelo","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Wali, G., Kumar, K.R., Liyanage, E., Davis, R.L., Mackay-Sim, A., and Sue, C.M. (2020). Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem Cells. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00820"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20503121231221941","DOI":"10.1177\/20503121231221941","article-title":"Hereditary spastic paraplegia: Novel insights into the pathogenesis and management","volume":"12","author":"Awuah","year":"2024","journal-title":"SAGE Open Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"115025","DOI":"10.1016\/j.expneurol.2024.115025","article-title":"Ighmbp2 mutations and disease pathology: Defining differences that differentiate SMARD1 and CMT2S","volume":"383","author":"Ahmed","year":"2025","journal-title":"Exp. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Sierra-Delgado, J.A., Sinha-Ray, S., Kaleem, A., Ganjibakhsh, M., Parvate, M., Powers, S., Zhang, X., Likhite, S., and Meyer, K. (2023). In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders. Biology, 12.","DOI":"10.3390\/biology12060867"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.15698\/cst2020.04.217","article-title":"Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases","volume":"4","author":"Picchiarelli","year":"2020","journal-title":"Cell Stress"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Harley, J., and Patani, R. (2020). Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem-Cell-Derived Motor Neurons. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218346"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"30289","DOI":"10.1074\/jbc.M805517200","article-title":"Impaired protein aggregate handling and clearance underlie the pathogenesis of p97\/VCP-associated disease","volume":"283","author":"Ju","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Chivet, M., Marchioretti, C., Pirazzini, M., Piol, D., Scaramuzzino, C., Polanco, M.J., Romanello, V., Zuccaro, E., Parodi, S., and D\u2019Antonio, M. (2020). Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism. Cells, 9.","DOI":"10.3390\/cells9020325"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Takeuchi, T., and Nagai, Y. (2017). Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases. Brain Sci., 7.","DOI":"10.3390\/brainsci7100128"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-019-00790-9","article-title":"Molecular Mechanisms and Therapeutics for SBMA\/Kennedy\u2019s Disease","volume":"16","author":"Arnold","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12264-023-01115-9","article-title":"Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases","volume":"40","author":"Hu","year":"2024","journal-title":"Neurosci. Bull."},{"key":"ref_79","first-page":"2","article-title":"VCP-related myopathy: A case series and a review of literature","volume":"42","author":"Iannibelli","year":"2023","journal-title":"Acta Myol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nmd.2016.05.001","article-title":"Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene","volume":"26","author":"Matsubara","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","article-title":"Intercellular Spread of Protein Aggregates in Neurodegenerative Disease","volume":"34","author":"Davis","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocn.2019.03.063","article-title":"Distal myopathy and rapidly progressive dementia associated with a novel mutation in the VCP gene: Expanding inclusion body myopathy with early-onset Paget disease and frontotemporal dementia spectrum","volume":"64","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Yi, J., Zhao, X., Noell, C.R., Helmer, P., Solmaz, S.R., and Vallee, R.B. (2023). Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. PLoS Genet., 19.","DOI":"10.1371\/journal.pgen.1010642"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s10038-020-0803-1","article-title":"The clinical-phenotype continuum in DYNC1H1-related disorders\u2014Genomic profiling and proposal for a novel classification","volume":"65","author":"Becker","year":"2020","journal-title":"J. Hum. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/awae183","article-title":"The expanding clinical and genetic spectrum of DYNC1H1-related disorders","volume":"148","author":"Becker","year":"2025","journal-title":"Brain"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Rhine, K., Al-Azzam, N., Yu, T., and Yeo, G.W. (2022). Aging RNA granule dynamics in neurodegeneration. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.991641"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-025-00839-8","article-title":"Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration","volume":"20","author":"Kellett","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Park, J.I. (2023). MAPK-ERK Pathway. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119666"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Tenreiro, S., Eckermann, K., and Outeiro, T.F. (2014). Protein phosphorylation in neurodegeneration: Friend or foe?. Front. Mol. Neurosci., 7.","DOI":"10.3389\/fnmol.2014.00042"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00401-019-01964-7","article-title":"Disrupted neuronal trafficking in amyotrophic lateral sclerosis","volume":"137","author":"Burk","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Rzepnikowska, W., Kaminska, J., and Kocha\u0144ski, A. (2024). The molecular mechanisms that underlie IGHMBP2-related diseases. Neuropathol. Appl. Neurobiol., 50.","DOI":"10.1111\/nan.13005"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Sahana, T.G., and Zhang, K. (2021). Mitogen-Activated Protein Kinase Pathway in Amyotrophic Lateral Sclerosis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080969"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2015.10.003","article-title":"Modeling ALS and FTD with iPSC-derived neurons","volume":"1656","author":"Lee","year":"2017","journal-title":"Brain Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-025-02179-x","article-title":"Protein kinases in neurodegenerative diseases: Current understandings and implications for drug discovery","volume":"10","author":"Wu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Choi, H.J., Cha, S.J., Lee, J.W., Kim, H.J., and Kim, K. (2020). Recent Advances on the Role of GSK3\u03b2 in the Pathogenesis of Amyotrophic Lateral Sclerosis. Brain Sci., 10.","DOI":"10.3390\/brainsci10100675"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"120753","DOI":"10.1016\/j.jns.2023.120753","article-title":"Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms","volume":"452","author":"Lee","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/21678421.2020.1837173","article-title":"Neuropathology of primary lateral sclerosis","volume":"21","author":"Mackenzie","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.24633","article-title":"GSK3\u00df-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model","volume":"79","author":"Mishra","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"G\u00fcner, F., Pozner, T., Krach, F., Prots, I., Loskarn, S., Schl\u00f6tzer-Schrehardt, U., Winkler, J., Winner, B., and Regensburger, M. (2021). Axon-Specific Mitochondrial Pathology in SPG11 Alpha Motor Neurons. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.680572"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.mcn.2004.02.009","article-title":"p38\u03b1 stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis","volume":"26","author":"Ackerley","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"934.e5","DOI":"10.1016\/j.neurobiolaging.2013.09.016","article-title":"hnRNPA2B1 and hnRNPA1 mutations are rare in patients with \u201cmultisystem proteinopathy\u201d and frontotemporal lobar degeneration phenotypes","volume":"35","author":"Nicolas","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1074\/jbc.M116.762898","article-title":"Mutations in valosin-containing protein (VCP) decrease ADP\/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons","volume":"292","author":"Ludtmann","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Malik, B., Devine, H., Patani, R., La Spada, A.R., Hanna, M.G., and Greensmith, L. (2019). Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-40118-3"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e08493","DOI":"10.7554\/eLife.08493","article-title":"Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy","volume":"4","author":"Todd","year":"2015","journal-title":"Elife"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12031-015-0676-5","article-title":"Targeted Molecular Therapies for SBMA","volume":"58","author":"Rinaldi","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Albert-Gasc\u00f3, H., Ros-Bernal, F., Castillo-G\u00f3mez, E., and Olucha-Bordonau, F.E. (2020). MAP\/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124471"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.coph.2004.03.009","article-title":"The p38 MAP kinase pathway as a therapeutic target in inflammatory disease","volume":"4","author":"Saklatvala","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pediatrneurol.2014.09.003","article-title":"Exome Sequencing Identifies DYNC1H1 Variant Associated With Vertebral Abnormality and Spinal Muscular Atrophy With Lower Extremity Predominance","volume":"52","author":"Punetha","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/ene.14173","article-title":"Clinical spectrum of BICD2 mutations","volume":"27","author":"Frasquet","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Unger, A., Roos, A., Gangfu\u00df, A., Hentschel, A., Gl\u00e4ser, D., Krause, K., Doering, K., Schara-Schmidt, U., Hoffjan, S., and Vorgerd, M. (2023). Microscopic and Biochemical Hallmarks of BICD2-Associated Muscle Pathology toward the Evaluation of Novel Variants. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076808"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41420-023-01531-w","article-title":"Rapid degeneration of iPSC-derived motor neurons lacking Gdap1 engages a mitochondrial-sustained innate immune response","volume":"9","author":"Prieto","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"103679","DOI":"10.1016\/j.dnarep.2024.103679","article-title":"DNA repair deficiencies and neurodegeneration","volume":"138","author":"Ropert","year":"2024","journal-title":"DNA Repair"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Konopka, A., and Atkin, J.D. (2022). DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.786420"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Kim, W., Kim, D.Y., and Lee, K.H. (2021). RNA-Binding Proteins and the Complex Pathophysiology of ALS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052598"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/acs.jproteome.9b00575","article-title":"Changes to the TDP-43 and FUS Interactomes Induced by DNA Damage","volume":"19","author":"Kawaguchi","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"103699","DOI":"10.1016\/j.dnarep.2024.103699","article-title":"Broken strands, broken minds: Exploring the nexus of DNA damage and neurodegeneration","volume":"140","author":"Stavgiannoudaki","year":"2024","journal-title":"DNA Repair"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-019-0874-4","article-title":"DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations","volume":"8","author":"Kim","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41418-022-01074-0","article-title":"C9orf72 functions in the nucleus to regulate DNA damage repair","volume":"30","author":"He","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"110217","DOI":"10.1016\/j.neuropharm.2024.110217","article-title":"Mitochondrial DAMPs: Key mediators in neuroinflammation and neurodegenerative disease pathogenesis","volume":"264","author":"Yu","year":"2025","journal-title":"Neuropharmacology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/21678421.2020.1837177","article-title":"Genetics of primary lateral sclerosis","volume":"21","author":"Silani","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_123","first-page":"5021694","article-title":"Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention","volume":"2020","author":"Montezinho","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/acn3.64","article-title":"Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11","volume":"1","author":"Chang","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s13311-013-0210-9","article-title":"Chromatin modifications associated with DNA double-strand breaks repair as potential targets for neurological diseases","volume":"10","author":"Brochier","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref_126","first-page":"160","article-title":"Oxidative DNA Damage: A Role in Altering Neuronal Function","volume":"3","author":"Behrouzi","year":"2022","journal-title":"J. Cell Signaling"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-008-0402-7","article-title":"Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): Determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease","volume":"87","author":"Guenther","year":"2009","journal-title":"J. Mol. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e1500078","DOI":"10.1126\/sciadv.1500078","article-title":"Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model","volume":"1","author":"Nizzardo","year":"2015","journal-title":"Sci. Adv."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1007\/s00018-020-03492-0","article-title":"Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"77","author":"Perego","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ncb2407","article-title":"Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system","volume":"14","author":"Meyer","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200908115","article-title":"Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease","volume":"187","author":"Ju","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4161\/cc.9.8.11298","article-title":"Involvement of Matrin 3 and SFPQ\/NONO in the DNA damage response","volume":"9","author":"Salton","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molcel.2012.04.009","article-title":"R loops: From transcription byproducts to threats to genome stability","volume":"46","author":"Aguilera","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.stem.2014.03.004","article-title":"Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1","volume":"14","author":"Kiskinis","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_135","first-page":"134","article-title":"The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activity","volume":"3","author":"Belikov","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tips.2010.08.005","article-title":"Therapeutic approaches to spinal and bulbar muscular atrophy","volume":"31","author":"Ranganathan","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ncb2367","article-title":"The ubiquitin-selective segregase VCP\/p97 orchestrates the response to DNA double-strand breaks","volume":"13","author":"Meerang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/auto.6.2.11014","article-title":"VCP\/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD","volume":"6","author":"Tresse","year":"2010","journal-title":"Autophagy"},{"key":"ref_139","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Inclusion Body Myopathy with Paget Disease of Bone and\/or Frontotemporal Dementia. GeneReviews(\u00ae), University of Washington."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1083\/jcb.201703201","article-title":"Disease-associated mutations in human BICD2 hyperactivate motility of dynein-dynactin","volume":"216","author":"Huynh","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Malamos, P., Papanikolaou, C., Gavriatopoulou, M., Dimopoulos, M.A., Terpos, E., and Souliotis, V.L. (2024). The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202405.0832.v1"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e101801","DOI":"10.15252\/embj.2019101801","article-title":"DNA damage kinase signaling: Checkpoint and repair at 30 years","volume":"38","author":"Lanz","year":"2019","journal-title":"EMBO J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neuron.2011.06.003","article-title":"Mitochondria: The next (neurode)generation","volume":"70","author":"Schon","year":"2011","journal-title":"Neuron"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","article-title":"The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nn.3514","article-title":"Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons","volume":"16","author":"Wang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12967-023-04493-w","article-title":"Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells","volume":"21","author":"Araya","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"101128","DOI":"10.1016\/j.arr.2020.101128","article-title":"Inter and Intracellular mitochondrial trafficking in health and disease","volume":"62","author":"Shanmughapriya","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40478-024-01866-0","article-title":"A pathogenic mutation in the ALS\/FTD gene VCP induces mitochondrial hypermetabolism by modulating the permeability transition pore","volume":"12","author":"Vanderhaeghe","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/21678421.2020.1837175","article-title":"Better understanding the neurobiology of primary lateral sclerosis","volume":"21","author":"Ozdinler","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Obrador, E., Salvador, R., L\u00f3pez-Blanch, R., Jihad-Jebbar, A., Vall\u00e9s, S.L., and Estrela, J.M. (2020). Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis. Antioxidants, 9.","DOI":"10.3390\/antiox9090901"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Votsi, C., Ververis, A., Nicolaou, P., Christou, Y.P., Christodoulou, K., and Zamba-Papanicolaou, E. (2021). A Novel SPG7 Gene Pathogenic Variant in a Cypriot Family With Autosomal Recessive Spastic Ataxia. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.812640"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1093\/hmg\/ddu200","article-title":"Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia","volume":"23","author":"Mishra","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/jcmm.14874","article-title":"Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights","volume":"24","author":"Saladini","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11427-016-5089-3","article-title":"Mitochondrial Ca(2+) uptake in skeletal muscle health and disease","volume":"59","author":"Zhou","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2013.02.028","article-title":"Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels","volume":"78","author":"Bartolome","year":"2013","journal-title":"Neuron"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","article-title":"\u03b1-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca(2+) homeostasis and mitochondrial ATP production","volume":"134","author":"Paillusson","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Zilio, E., Piano, V., and Wirth, B. (2022). Mitochondrial Dysfunction in Spinal Muscular Atrophy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810878"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Beitel, L.K., Alvarado, C., Mokhtar, S., Paliouras, M., and Trifiro, M. (2013). Mechanisms mediating spinal and bulbar muscular atrophy: Investigations into polyglutamine-expanded androgen receptor function and dysfunction. Front. Neurol., 4.","DOI":"10.3389\/fneur.2013.00053"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1091\/mbc.E21-03-0097","article-title":"VPS13D interacts with VCP\/p97 and negatively regulates endoplasmic reticulum-mitochondria interactions","volume":"32","author":"Du","year":"2021","journal-title":"Mol. Biol. Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuron.2012.02.025","article-title":"Dynactin is required for transport initiation from the distal axon","volume":"74","author":"Moughamian","year":"2012","journal-title":"Neuron"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1007\/s00415-015-7727-2","article-title":"Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1","volume":"262","author":"Strickland","year":"2015","journal-title":"J. Neurol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1093\/emboj\/cdg592","article-title":"Bicaudal D induces selective dynein-mediated microtubule minus end-directed transport","volume":"22","author":"Hoogenraad","year":"2003","journal-title":"EMBO J."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Kodavati, M., Wang, H., and Hegde, M.L. (2020). Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective. Cells, 9.","DOI":"10.3390\/cells9041065"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.fmre.2023.04.002","article-title":"Neuroimmune interactions and their roles in neurodegenerative diseases","volume":"4","author":"Chen","year":"2024","journal-title":"Fundam. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-018-1933-9","article-title":"Inflammation in ALS\/FTD pathogenesis","volume":"137","author":"McCauley","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Hiew, J.Y., Lim, Y.S., Liu, H., and Ng, C.S. (2025). Integrated transcriptomic profiling reveals a STING-mediated Type II Interferon signature in SOD1-mutant amyotrophic lateral sclerosis models. Commun. Biol., 8.","DOI":"10.1038\/s42003-025-07790-w"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.brainresbull.2009.07.012","article-title":"Astrocytic dysfunction: Insights on the role in neurodegeneration","volume":"80","author":"Rossi","year":"2009","journal-title":"Brain Res. Bull."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nicl.2017.10.024","article-title":"Imaging of glia activation in people with primary lateral sclerosis","volume":"17","author":"Paganoni","year":"2018","journal-title":"Neuroimage Clin."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Mahmoud, S., Gharagozloo, M., Simard, C., and Gris, D. (2019). Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release. Cells, 8.","DOI":"10.3390\/cells8020184"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Toupenet Marchesi, L., Leblanc, M., and Stevanin, G. (2021). Current Knowledge of Endolysosomal and Autophagy Defects in Hereditary Spastic Paraplegia. Cells, 10.","DOI":"10.3390\/cells10071678"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-023-01409-x","article-title":"ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in Spinal Muscular Atrophy motoneurons","volume":"9","author":"Sansa","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri.2016.144","article-title":"T cell responses in the central nervous system","volume":"17","author":"Korn","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","article-title":"Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity","volume":"16","author":"Palazzolo","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2174\/0929867326666181129095309","article-title":"Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review","volume":"27","author":"Sharma","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajpath.2012.07.008","article-title":"Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: Lessons from conditional AR knockout mice","volume":"181","author":"Lai","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mus.27097","article-title":"Multisystem proteinopathy: Where myopathy and motor neuron disease converge","volume":"63","author":"Korb","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40478-020-00909-6","article-title":"Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy","volume":"8","author":"Rossor","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1083129","article-title":"Mutations in dynein link motor neuron degeneration to defects in retrograde transport","volume":"300","author":"Hafezparast","year":"2003","journal-title":"Science"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(02)00696-7","article-title":"Disruption of Dynein\/Dynactin Inhibits Axonal Transport in Motor Neurons Causing Late-Onset Progressive Degeneration","volume":"34","author":"LaMonte","year":"2002","journal-title":"Neuron"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","article-title":"Innate immune activation in neurodegenerative diseases","volume":"57","author":"Heneka","year":"2024","journal-title":"Immunity"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuron.2009.08.038","article-title":"Immune Influence on Adult Neural Stem Cell Regulation and Function","volume":"64","author":"Carpentier","year":"2009","journal-title":"Neuron"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17582024.2024.2402216","article-title":"Tofersen for SOD1 ALS","volume":"14","author":"Everett","year":"2024","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_192","first-page":"340","article-title":"RNA-Based Therapies for Neurodegenerative Diseases","volume":"118","author":"Ayala","year":"2021","journal-title":"Mo. Med."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Huang, S., Hao, X.Y., Li, Y.J., Wu, J.Y., Xiang, D.X., and Luo, S. (2022). Nonviral delivery systems for antisense oligonucleotide therapeutics. Biomater. Res., 26.","DOI":"10.1186\/s40824-022-00292-4"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","article-title":"Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities","volume":"93","author":"Menzies","year":"2017","journal-title":"Neuron"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.omtn.2022.10.012","article-title":"Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases","volume":"30","author":"Chernega","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e11589","DOI":"10.15252\/emmm.201911589","article-title":"Metabolic effects of bezafibrate in mitochondrial disease","volume":"12","author":"Steele","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Harding, E.C., Chen, H.-J.C., Shepilov, D., Zhang, S.O., Rowley, C., Mali, I., Chen, J., Stewart, N., Swinden, D., and Washer, S.J. (2024). Unbiased preclinical phenotyping reveals neuroprotective properties of pioglitazone. bioRxiv.","DOI":"10.1101\/2024.08.30.610328"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14728222.2018.1526925","article-title":"Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging","volume":"22","author":"Duda","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e46171","DOI":"10.15252\/embr.201846171","article-title":"Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures","volume":"19","author":"Sousa","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Guo, N., Huang, W., Huang, J., Liu, Y., Zhu, K., and Gao, W. (2025). Global research trends in biomarkers, therapeutic targets, and drugs for amyotrophic lateral sclerosis: A bibliometric and visualization analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1588968"},{"key":"ref_201","unstructured":"uniQure (2025, January 30). uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for Its Phase I\/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS. Available online: https:\/\/uniqure.gcs-web.com\/news-releases\/news-release-details\/uniqure-announces-favorable-recommendation-independent-data."},{"key":"ref_202","unstructured":"Spinogenix (2025, May 05). Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment of ALS. Available online: https:\/\/www.spinogenix.com\/spinogenix-announces-fda-authorized-expanded-access-programfor-spg302-the-first-synaptic-regenerative-therapy-to-treat-als\/."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40261-024-01410-x","article-title":"Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I\/Ib, Open-Label, Escalating Dose and Extended Access Study","volume":"45","author":"Gerometta","year":"2025","journal-title":"Clin. Drug Investig."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Wu, Y.F., Chen, J.A., and Jong, Y.J. (2025). Treating neuromuscular diseases: Unveiling gene therapy breakthroughs and pioneering future applications. J. Biomed. Sci., 32.","DOI":"10.1186\/s12929-025-01123-z"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ymthe.2025.04.045","article-title":"Current clinical applications of AAV-mediated gene therapy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12964-025-02351-4","article-title":"Targeting androgen receptor stability and degradation: Approaches for developing a therapy for spinal and bulbar muscular atrophy","volume":"23","author":"Cristofani","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_207","unstructured":"NeurologyLive (2025, June 04). AJ201 Demonstrates Promising Phase 1\/2 Results in Spinal and Bulbar Muscular Atrophy. Available online: https:\/\/www.neurologylive.com\/view\/aj201-demonstrates-promising-phase-1-2-results-spinal-bulbar-muscular-atrophy."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.nmd.2023.07.021","article-title":"O06 Clinical trial readiness and validation of onsite and remote evaluation in valosin-containing protein-associated multisystem proteinopathy: A 24-month longitudinal study","volume":"33","author":"Reash","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"107836","DOI":"10.1016\/j.phrs.2025.107836","article-title":"Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes","volume":"218","author":"Vantaggiato","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tins.2010.02.003","article-title":"RNA metabolism and the pathogenesis of motor neuron diseases","volume":"33","author":"Lemmens","year":"2010","journal-title":"Trends Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7644\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:25:33Z","timestamp":1760034333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":210,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157644"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157644","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}